MedPath

Pharmacokinetics study of drinks containing functional ingredient.

Not Applicable
Conditions
Healthy male adults
Registration Number
JPRN-UMIN000052580
Lead Sponsor
CPCC Company Limited.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Male
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Subjects who are with treatment. (2)Subjects who are with history of gastrointestinal surgery. (3) Subjects with a maximal blood pressure of less than 90 mmHg. (4) Subjects who donated their blood components and/or whole blood (0.2 L) within the past 4 weeks. (5) Subjects who donated their whole blood (0.4 L) within the past 12 weeks. (6) Subjects being collected in total of their blood (1.2 L) within the past 12 months and in this research. (7) Subjects being under other clinical tests, or partook in those within the past four weeks, or will join those after the consent. (8) Subjects who meet any of the following: (a) suffering from heart, liver, or kidney disease (including complications of other diseases) (b) having a history of cardiovascular disease (c) diabetes (d) allergic to the test food and required one. (9) Subjects having drug or food allergy. (10) Subjects having severe anemia (11) Subjects who have experience illness or deterioration of physical condition due to blood sampling in the past. (12) Subjects who have difficulty in having blood drawn from a peripheral blood vein. (13) Subjects with excessive alcohol intake. (14) Subjects having a habit of smoking. (15) Subjects having extremely irregular eating habits. (16) Shift workers or late night workers. (17) Patients who have used medicines within one week prior to consumption of the test food (18) Subjects who have periodically used health-specific / functional / health foods including supplements, which might affect the test. (19) Subjects who are not negative for HBs antigen, HCV antibody test. (20) Others who were judged as inappropriate for participation by the principal/sub investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AUC
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath